Vaccine (Oncology)

Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants.
[19034678] Angiogenesis 11(4): 381-93 (2008)

Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.
[17273909] Angiogenesis 10(1): 23-34 (2007)

Recent advances in cancer vaccines: an overview.
[19015149] Jpn J Clin Oncol 39(2): 73-80 (2009)

Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions.
[17521316] Cancer Sci 98(8): 1139-46 (2007)

The critical role of type-1 innate and acquired immunity in tumor immunotherapy.
[15471553] Cancer Sci 95(9): 697-703 (2004)

Targeting the stroma by T cells to limit tumor growth.
[19047130] Cancer Res 68(23): 9570-3 (2008)

Mechanism and therapeutic reversal of immune suppression in cancer.
[17545581] Cancer Res 67(11): 5067-9 (2007)

Perspectives of gammadelta T cells in tumor immunology.
[17210676] Cancer Res 67(1): 5-8 (2007)

Regulation of tumor progression by anti-neoplastic T cell responses.
[14739786] Cancer Biol Ther 3(2): 140-6 (2004)

Checkpoint blockade in cancer immunotherapy.
[16730267] Adv Immunol 90(-): 297-339 (2006)

Clinical cancer therapy by NK cells via antibody-dependent cell-mediated cytotoxicity.
[21660134] J Biomed Biotechnol 2011(-): 379123 (2011)

Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines.
[21541197] J Biomed Biotechnol 2011(-): 910836 (2011)

Profile of a serial killer: cellular and molecular approaches to study individual cytotoxic T-cells following therapeutic vaccination.
[21113290] J Biomed Biotechnol 2011(-): 452606 (2011)

RNA vaccines in cancer treatment.
[20625504] J Biomed Biotechnol 2010(-): 623687 (2010)

Strategies for cancer vaccine development.
[20706612] J Biomed Biotechnol 2010(-): - (2010)

TAA polyepitope DNA-based vaccines: a potential tool for cancer therapy.
[20617190] J Biomed Biotechnol 2010(-): 102758 (2010)

Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience.
[20625438] J Biomed Biotechnol 2010(-): 692097 (2010)

Recent advancements in cytotoxic T lymphocyte generation methods using carbohydrate-coated liposomes.
[20617143] J Biomed Biotechnol 2010(-): 242539 (2010)

Bridging innate and adaptive antitumor immunity targeting glycans.
[20617150] J Biomed Biotechnol 2010(-): 354068 (2010)

Therapeutic cancer vaccines in combination with conventional therapy.
[20617155] J Biomed Biotechnol 2010(-): 237623 (2010)

Chimeric antigen receptor-engineered T cells for immunotherapy of cancer.
[20467460] J Biomed Biotechnol 2010(-): 956304 (2010)

DNA vaccines: developing new strategies against cancer.
[20368780] J Biomed Biotechnol 2010(-): 174378 (2010)

Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy.
[20224660] J Biomed Biotechnol 2010(-): 705215 (2010)

Vaccines against human carcinomas: strategies to improve antitumor immune responses.
[20300434] J Biomed Biotechnol 2010(-): 380697 (2010)

TCR-engineered, customized, antitumor T cells for cancer immunotherapy: advantages and limitations.
[21218269] ScientificWorldJournal 11(-): 121-9 (2011)

GM-CSF-secreting vaccines for solid tumors: moving forward.
[20670599] Discov Med 10(50): 52-60 (2010)

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.
[19934295] Clin Cancer Res 15(23): 7412-20 (2009)

Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms.
[16914564] Clin Cancer Res 12(16): 4794-803 (2006)

Immunotherapy of cancer: key findings and commentary on the third Tegernsee conference.
[20061401] Oncologist 15(1): 112-8 (2010)

Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.
[20143445] Cancer 116(7): 1638-45 (2010)

Immunotherapy of metastatic renal cell carcinoma.
[19402060] Cancer 115(10 Suppl): 2298-305 (2009)

Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities.
[20631071] Cancer Res 70(15): 6109-13 (2010)

Dendritic cell-derived exosomes for cancer immunotherapy: what's next?
[20145139] Cancer Res 70(4): 1281-5 (2010)

Tumor-specific T-cell memory: clearing the regulatory T-cell hurdle.
[18339838] Cancer Res 68(6): 1614-7 (2008)

A promising cancer vaccine.
[21417898] Future Oncol 7(3): 331-4 (2011)

New perspectives in cancer immunotherapy and immunomonitoring.
[19792962] Future Oncol 5(7): 941-4 (2009)

Cancer vaccines for hematologic malignancies.
[11965234] Cancer Control 9(2): 138-51 (2002)

Pharmacologic and chemical adjuvants in tumor virotherapy.
[19462957] Chem Rev 109(7): 3125-40 (2009)

Mobilizing the low-avidity T cell repertoire to kill tumors.
[17651986] Semin Cancer Biol 17(4): 317-29 (2007)

Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors.
[17656106] Semin Cancer Biol 17(4): 299-308 (2007)

Toward effective immunotherapy for the treatment of malignant brain tumors.
[19560742] Neurotherapeutics 6(3): 527-38 (2009)

Advances in tumour immunotherapy.
[18477644] QJM 101(9): 675-83 (2008)

Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models.
[21394107] Cancer Gene Ther 18(6): 407-18 (2011)

Adoptive cell transfer: a clinical path to effective cancer immunotherapy.
[18354418] Nat Rev Cancer 8(4): 299-308 (2008)

Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.
[18422783] Br J Haematol 142(2): 179-91 (2008)

Immunotherapy targeting EBV-expressing lymphoproliferative diseases.
[18790446] Best Pract Res Clin Haematol 21(3): 405-20 (2008)

Immunotherapy of childhood cancer: from biologic understanding to clinical application.
[19952749] Curr Opin Pediatr 22(1): 2-11 (2010)

Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma.
[21423545] J Oncol 2011(-): 982425 (2011)

Idiotype vaccines for lymphoma: Potential factors predicting the induction of immune responses.
[21773074] World J Clin Oncol 2(6): 237-44 (2011)

New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future.
[21939556] Ital J Pediatr 37(-): 46 (2011)

Dendritic cells: are they clinically relevant?
[20693842] Cancer J 16(4): 318-24 (2010)

Cellular vaccine approaches.
[20693840] Cancer J 16(4): 304-10 (2010)

Novel immunotherapies.
[20010170] Cancer J 15(6): 502-10 (2009)

Cytokine induced killer cells as promising immunotherapy for solid tumors.
[21716717] J Cancer 2(-): 363-8 (2011)

Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens.
[21151581] J Cancer 1(-): 230-41 (2010)

Clinical applications of a peptide-based vaccine for glioblastoma.
[19944970] Neurosurg Clin N Am 21(1): 95-109 (2010)

Dendritic cell vaccines for brain tumors.
[19944973] Neurosurg Clin N Am 21(1): 139-57 (2010)

Immunotherapy for cancer: synthetic carbohydrate-based vaccines.
[19724783] Chem Commun (Camb) -(36): 5335-49 (2009)

Improvement of different vaccine delivery systems for cancer therapy.
[21211062] Mol Cancer 10(-): 3 (2011)

WT1 peptide vaccine, one of the most promising cancer vaccines: its present status and the future prospects.
[20874639] Immunotherapy 2(5): 591-4 (2010)

Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer.
[21751946] Immunotherapy 3(7): 805-7 (2011)

Personalized dendritic cell-based tumor immunotherapy.
[20161666] Immunotherapy 2(1): 57-68 (2010)

Overcoming doubts and other obstacles in the development of effective peptide-based therapeutic vaccines against cancer.
[20370542] Expert Rev Vaccines 9(4): 343-5 (2010)

Cancer vaccines in hematologic malignancies: advances, challenges and therapeutic potential.
[20450317] Expert Rev Vaccines 9(5): 451-4 (2010)

Recombinant lentivector as a genetic immunization vehicle for antitumor immunity.
[18377355] Expert Rev Vaccines 6(6): 913-24 (2007)

Cellular and vaccine therapeutic approaches for gliomas.
[20946667] J Transl Med 8(-): 100 (2010)

INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect.
[20420527] Expert Opin Biol Ther 10(6): 983-91 (2010)

Immune-based therapeutics for pediatric cancer.
[19947897] Expert Opin Biol Ther 10(2): 163-78 (2010)

Mimotope vaccination--from allergy to cancer.
[19344285] Expert Opin Biol Ther 9(4): 493-506 (2009)

Immunotherapeutic approaches for glioma.
[19348609] Crit Rev Immunol 29(1): 1-42 (2009)

Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment.
[21327055] Bioeng Bugs 1(4): 235-43 (2010)

An update on TroVax for the treatment of progressive castration-resistant prostate cancer.
[21691576] Onco Targets Ther 4(-): 33-41 (2011)

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium.
[19259668] Cancer Immunol Immunother 58(10): 1701-13 (2009)

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.
[17721783] Cancer Immunol Immunother 57(3): 289-302 (2008)

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI).
[17721781] Cancer Immunol Immunother 57(3): 303-15 (2008)

Targeting gammadelta T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application.
[21159627] Cancer Res 70(24): 10024-7 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Vaccine (Oncology).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Vaccine (Oncology).php on line 92